Rigorously tested and continuously validated in practice, Cytel software is used at thousands of pharmaceutical, biotech, medical device companies, and leading independent research institutes.
Cytel’s cutting-edge trial design and implementation expertise, with a specialty in adaptive trials, is helping sponsor companies of all sizes to increase success rates in clinical development.
Adaptive Dose-Escalation and Trial Prediction in East® v6.3
New dose-escalation designs, gatekeeping procedures for multiple endpoints, and interim analysis trial prediction tools, continue East® software’s twenty year tradition of reliable innovation.
Adaptive Design Workshops at JSM 2014
JSM workshops teach use of East® 6.3 modules to design dose-escalation studies, simulate testing strategies for multiple endpoints, and predict a trial’s future course.
Register for EUGM 2014: East® User Group Meeting
Our annual EUGM begins with East software training on Oct 21. The Oct 22 adaptive trial innovations Open Meeting features guests LJ Wei, Michael Proshan, and Ashwin Gollerkeri.
What Clients Say
Simona Skerjanec, VP Medical Science
The Medicines Company
Steven B. Ketchum, VP Research and Development
Joe Heyes, VP
Early Stage Biostatistics Merck
Dr. Scott Harris, CMO
Dr. Patrice Rioux, VP, CMO
Sylvain Nicolas, Global Head Biostatistics Phase 1 Studies